S.C(SZ:300724) Changjiang Securities·2025-05-20 02:12Investment Rating - The report maintains a "Buy" rating for the company [10] Core Views - The company reported strong revenue and performance growth for 2024 and Q1 2025, primarily benefiting from the acceptance of existing orders, demonstrating strong operational resilience [2][6] - Despite pressure on profitability due to impairment provisions, the company's cost control capabilities continue to improve [2][8] - The company is solidifying its market competitiveness across multiple technology routes, including TOPCon, HJT, and perovskite, and has achieved significant order breakthroughs in the semiconductor equipment sector [2][8] Summary by Sections Financial Performance - In 2024, the company achieved revenue of 18.887 billion, a year-on-year increase of 116.26%; net profit attributable to shareholders was 2.764 billion, up 69.18%; and net profit excluding non-recurring items was 2.566 billion, up 68.23% [6] - For Q1 2025, revenue reached 4.099 billion, a year-on-year increase of 58.95%; net profit attributable to shareholders was 708 million, up 22.42%; and net profit excluding non-recurring items was 637 million, up 15.49% [6] Business Development - The company continues to enhance its long-term competitive capabilities through platform-based business layouts [8] - In the TOPCon technology route, the company maintains a leading market share amid industry upgrades and new capacity demands [8] - The HJT technology route has seen the company's trial production line achieve an average conversion efficiency of 25.6% [8] - The perovskite technology route has successfully delivered large-scale coating equipment and initiated trial production [8] - In the semiconductor equipment sector, the company has secured orders for silicon carbide wet processing equipment, marking comprehensive coverage of the etching and cleaning processes for silicon carbide devices [8] Profitability and Cost Control - The company's gross profit margin for 2024 was 26.46%, a decrease of 2.49 percentage points year-on-year, while the expense ratio improved to 4.73%, down 3.18 percentage points [8] - The net profit margin for 2024 was 14.65%, down 4.12 percentage points year-on-year, impacted by significant impairment losses [8] - The company’s ability to control expenses remains strong, with a continued focus on maintaining good levels of cost management [8]